FRIDAY, July 30, 2021 (HealthDay News) — Death rates from Alzheimer’s disease are particularly high in the rural United States, a preliminary study finds, highlighting a need for health care resources in traditionally under-served areas. Researchers discovered that over the past two decades, rural areas in the Southeast have seenContinue Reading

WEDNESDAY, July 28, 2021 (HealthDay News) — An outside advisor to the U.S. Food and Drug Administration’s review of the controversial Alzheimer’s drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable collaboration between regulators and the drug’s maker. “I’m not surprisedContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefullyContinue Reading